Advances in Kaposi's sarcoma Journal Article


Authors: Myskowski, P. L.; Ahkami, R.
Article Title: Advances in Kaposi's sarcoma
Abstract: KS remains a challenge to clinicians and investigators more than a century after its initial description. Debate continues as to the cell of origin, as well as whether or not it is a true cancer. KS appears to be an opportunistic neoplasm, which in its earliest phase retains some features of a benign hyperproliferative process, but in its late stages behaves like an aggressive malignancy. Pathogenesis seems to involve a predisposed individual (genetically susceptible or immunologically compromised) who comes into contact with an infectious agent, most likely a virus. Cytokines appear to play a major role in the growth of the tumor. The exact role of the KSHV in this process will likely be the subject of much investigation in the future.
Keywords: pathogenesis; review; interferon; cancer diagnosis; disease association; gene expression; skin neoplasms; palliative therapy; antineoplastic activity; angiogenesis; cytokine; herpes virus; interleukin 6; forecasting; antivirus agent; kaposi sarcoma; sarcoma, kaposi; evaluation studies; immunosuppressive treatment; retinoid; clinical trials; antiviral activity; zidovudine; fumagillol chloroacetylcarbamate; interleukin 1; tecogalan; humans; priority journal; thrombocyte factor
Journal Title: Dermatologic Clinics
Volume: 15
Issue: 1
ISSN: 0733-8635
Publisher: W.B. Saunders Co.  
Date Published: 1997-01-01
Start Page: 177
End Page: 188
Language: English
DOI: 10.1016/s0733-8635(05)70424-1
PUBMED: 9001870
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 17 March 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Patricia Myskowski
    216 Myskowski
Related MSK Work